We make Better Cannabinoids through sustainable biotechnology.
Hyasynth Bio has raised $1.9M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2021.
Hyasynth Bio's investors include SOSV, OrganiGram, MassChallenge, Anges Quebec, Hedgewood.
Hyasynth Bio is headquartered in Montréal, Canada.
We make Better Cannabinoids through sustainable biotechnology.
Hyasynth Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hyasynth Bio — Funding & Investors." VCBacked, December 22, 2021, https://www.vcbacked.co/company/hyasynth-bio. Accessed August 14, 2026.
VCBacked. (2021). Hyasynth Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hyasynth-bio
{{cite web |title=Hyasynth Bio — Funding & Investors |url=https://www.vcbacked.co/company/hyasynth-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated